Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Part of paid clinical trials in San Antonio, Texas.

Sponsor
The University of Texas Health Science Center at San Antonio
Study ID
NCT03894917
Status
Recruiting
Apply to this trial

Conditions

  • Carcinoma, Hepatocellular

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Comprehensive Geriatric Assessment (CGA) — OTHER
    Assessments will be done for participants that are 65 years or older.

Study Details

This is an observational, prospective cohort study that will recruit a diverse sample of 84 participants with newly diagnosed with unresectable, advanced hepatocellular carcinoma (HCC) at the UT Health Cancer Center in San Antonio. This study uses geriatric assessment tools with participants 65 years and older and collects adverse events and exploratory markers of aging for all participants.

Key Dates

Start date
Sep 13, 2019
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2027

Study Design

Enrollment
84 participants (estimated)

Arms

  • Arm: Group 1
    Participants 65 years or older
  • Arm: Group 2
    Participants less than 65 years

Primary Outcome Measure

Characterize the Change in disease and treatment patterns of advanced hepatocellular carcinoma (HCC) in older patients in the US. [ Time Frame: will be collected at time points: at screening, Month 1, Month 2, Month 4, Month 6, Month 8, Month 10 and Month 12. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mays Cancer CenterSan AntonioTexas78229
Gina Alvarez, RN
[email protected]
210-450-5893

Find similar trials in San Antonio, TX

By research site
Mays Cancer Center· San Antonio, TX

Related Studies